Circulating biomarkers in malignant pleural mesothelioma
Identification of Novel Markers for the Diagnosis of Malignant Pleural Mesothelioma - The American Journal of Pathology
Megakaryocyte potentiating factor as a tumor marker of malignant pleural mesothelioma: evaluation in comparison with mesothelin. | Semantic Scholar
Advances in Malignant Mesothelioma | NEJM
Redefining malignant pleural mesothelioma types as a continuum uncovers immune-vascular interactions - eBioMedicine
Evaluation of 12 antibodies for distinguishing epithelioid mesothelioma from adenocarcinoma: identification of a three-antibody immunohistochemical panel with maximal sensitivity and specificity | Modern Pathology
Disease volumes as a marker for patient response in malignant pleural mesothelioma - Annals of Oncology
Serum HMGB1 as a prognostic marker for malignant pleural mesothelioma
Frequent expression of conventional endothelial markers in pleural mesothelioma: usefulness of claudin-5 as well as combined traditional markers to distinguish mesothelioma from angiosarcoma - Lung Cancer
Ki67 (MIB-1) as a Prognostic Marker for Clinical Decision Making Before Extended Pleurectomy Decortication in Malignant Pleural Mesothelioma - JTO Clinical and Research Reports
Q&A column - CAP TODAY
Table 2 from Molecular profiling of malignant pleural mesothelioma and pulmonary fibrosis | Semantic Scholar
Malignant mesothelioma: A histomorphological and immunohistochemical study of 24 cases from a tertiary care hospital in Southern India Hui M, Uppin SG, Bhaskar K, Kumar NN, Paramjyothi GK - Indian J Cancer
Pathology Outlines - Diffuse malignant mesothelioma
Diagnostic Value of CYFRA 21–1 Tumor Marker and CEA in Pleural Effusion Due to Mesothelioma - CHEST
CLDN15 is a novel diagnostic marker for malignant pleural mesothelioma | Scientific Reports
Malignant Mesothelioma Marker Selection - Mesothelioma in Focus
Asbestos Exposure, Pleural Mesothelioma, and Serum Osteopontin Levels | NEJM
Frontiers | Liquid Biopsy in Malignant Pleural Mesothelioma: State of the Art, Pitfalls, and Perspectives
Progress in the Management of Malignant Pleural Mesothelioma in 2017 - Journal of Thoracic Oncology
Pilot Study to Evaluate Serum Soluble Mesothelin-Related Peptide (SMRP) as Marker for Clinical Monitoring of Pleural Mesotheliom
Markers for the non-invasive diagnosis of mesothelioma: a systematic review | British Journal of Cancer
Soluble markers for diagnosis of malignant pleural mesothelioma | Biomarkers in Medicine
Epithelioid Mesothelioma | Treatment, Prognosis & Diagnosis
Clinical utility of diagnostic biomarkers in malignant pleural mesothelioma: a systematic review and meta-analysis | European Respiratory Society
